
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM:WINT) through any online brokerage.
There are no as such competitors for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. has a consensus price target of $350.00.
The stock price for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM: WINT) is $0.0003 last updated September 18, 2026 at 1:01 PM EDT.
There are no upcoming dividends for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..
WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.